Ekso Bionics (EKSO)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	2.72 mm	2.72 mm	2.72 mm	2.72 mm	2.72 mm	2.72 mm
Cash burn (monthly)	840.00 k	464.17 k	467.33 k	920.58 k	687.00 k	741.92 k
Cash used (since last report)	2.03 mm	1.12 mm	1.13 mm	2.23 mm	1.66 mm	1.79 mm
Cash remaining	691.51 k	1.60 mm	1.59 mm	496.72 k	1.06 mm	928.60 k
Runway (months of cash)	0.8	3.4	3.4	0.5	1.5	1.3

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q4 2024

EKSO institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	35	18	+94.4%
Opened positions	19	5	+280.0%
Closed positions	2	2	–
Increased positions	2	1	+100.0%
Reduced positions	3	1	+200.0%

13F shares	Current	Prev Q	Change
Total value	2.46 bn	1.11 bn	+121.3%
Total shares	4.88 mm	1.80 mm	+171.6%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Armistice Capital	1.73 mm	$1.05 bn	NEW
Kent Lake PR	1.00 mm	$610.00 mm	NEW
Vanguard	594.43 k	$362.60 mm	0.0%
AZ Fund Management	423.00 k	$1.12 mm	0.0%
Intracoastal Capital	387.37 k	$0.00	0.0%
Cresset Asset Management	300.00 k	$183.00 mm	NEW
Geode Capital Management	163.94 k	$100.04 mm	-2.0%
Renaissance Technologies	75.92 k	$46.31 mm	+1.7%
BlackRock	54.75 k	$33.40 mm	0.0%
Puissance Cross-Border Opportunities II	29.83 k	$132.00 k	0.0%

Largest transactions	Shares	Bought/sold	Change
Armistice Capital	1.73 mm	+1.73 mm	NEW
Kent Lake PR	1.00 mm	+1.00 mm	NEW
Cresset Asset Management	300.00 k	+300.00 k	NEW
STT State Street	23.18 k	+23.18 k	NEW
Golden State Wealth Management	19.51 k	+19.51 k	NEW
HRT Financial	13.43 k	+13.43 k	NEW
Atria Wealth Solutions	0.00	-12.67 k	EXIT
Consolidated Portfolio Review	10.20 k	+10.20 k	NEW
Tower Research Capital	6.46 k	+6.46 k	NEW
Geode Capital Management	163.94 k	-3.37 k	-2.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

EKSO insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
9 Dec 25	Jerome Wong	Common Stock	Sell	Dispose S	No	No	4.7	1,238	5.82 k	24,771
9 Dec 25	Jones Jason C	Common Stock	Sell	Dispose S	No	No	4.7	270	1.27 k	26,941
10 Nov 25	Jones Jason C	Common Stock	Sell	Dispose S	No	No	4.8	9,723	46.67 k	27,211
10 Nov 25	Scott G. Davis	Common Stock	Sell	Dispose S	No	No	4.8	23,315	111.91 k	78,777
10 Nov 25	Jerome Wong	Common Stock	Sell	Dispose S	No	No	4.8	11,288	54.18 k	26,009

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

HC Wainwright & Co. Maintains Buy on Ekso Bionics Holdings, Raises Price Target to $6

18 Nov 25

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and raises the price target from $4 to $6.

Ekso Bionics Says Is In Process Of Exploring One Or More Strategic Transactions With Certain Third Parties; Transactions May Include Acquisition Of Line Of Business And/or Sale Of All Or Substantially All Of Co's Current Business

28 Oct 25

Exploration of Strategic TransactionsThe Company also announced today that it is in the process of exploring one or more strategic transactions with certain third parties, which transactions may include the acquisition

Ekso Bionics Holdings Q3 EPS $(0.54) Beats $(1.15) Estimate, Sales $4.227M Miss $4.346M Estimate

28 Oct 25

Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(1.15) by 52.84 percent. This is a 64.71 percent increase over losses of $(1.53) per share

Ekso Bionics Secures $2M Term Loan From B. Riley At 10% Interest, Matures September 14, 2026

17 Sep 25

Press releases

From Benzinga Pro

Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System

4 Dec 25

SAN RAFAEL, Calif. and TNUVOT, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and